Thomas Rathjen
Impact in
-
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
-
- Circular RNAs in diseases
- RNA modifications and cancer
- Metabolism, Diabetes, and Cancer
- RNA Research and Splicing
Papers in
-
- MicroRNA in disease regulation 4
- Cancer, Hypoxia, and Metabolism 1
-
- Metabolism, Diabetes, and Cancer 1
- FOXO transcription factor regulation 1
- Co-authors
- Matthew N. Poy (7 shared papers)Matthias Selbach (2 shared papers)Matthias D. Sury (2 shared papers)Hans‐Hermann Wessels (2 shared papers)Sudhir Gopal Tattikota (4 shared papers)Heike Naumann (1 shared paper)Francesca M. Spagnoli (1 shared paper)Marc R. Friedländer (2 shared papers)
- Journals
- Diabetes (1 paper)Journal of Biological Chemistry (1 paper)Arteriosclerosis Thrombosis and Vascular Biology (1 paper)Molecular & Cellular Proteomics (1 paper)Oncogene (1 paper)
- Partner nations
- GermanyUnited StatesDenmark
In The Last Decade
Thomas Rathjen
8 papers receiving 207 citations
Peers
Comparison fields: 5 of 56
- Cancer Research 92
- Molecular Biology 126
- Surgery 67
- Genetics 38
- Aging 2
Countries citing papers authored by Thomas Rathjen
This map shows the geographic impact of Thomas Rathjen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas Rathjen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas Rathjen more than expected).
Fields of papers citing papers by Thomas Rathjen
This network shows the impact of papers produced by Thomas Rathjen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas Rathjen. The network helps show where Thomas Rathjen may publish in the future.
Co-authors
The 25 scholars most cited alongside Thomas Rathjen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2015 | 57 | |
| 2 | 2013 | 37 | |
| 3 | 2018 | 36 | |
| 4 | 2017 | 26 | |
| 5 | 2017 | 20 | |
| 6 | 2016 | 17 | |
| 7 | 2022 | 7 | |
| 8 | 2017 | 7 | |
| 9 | 2025 | 0 | |
| 10 | Micro-managing the pancreatic {beta} cell | 2014 | 0 |
About Thomas Rathjen
Thomas Rathjen is a scholar working on Cancer Research, Molecular Biology, Surgery, Oncology and Epidemiology, having authored 10 papers that have together received 207 indexed citations. Recurring topics across this work include Pancreatic function and diabetes (4 papers), MicroRNA in disease regulation (4 papers), Metabolism, Diabetes, and Cancer (1 paper), FOXO transcription factor regulation (1 paper), Cancer, Hypoxia, and Metabolism (1 paper), Membrane Separation Technologies (1 paper), Biochemical Analysis and Sensing Techniques (1 paper) and Calcium signaling and nucleotide metabolism (1 paper). The work is most often cited by research in Cancer Research (92 citations), Molecular Biology (126 citations), Surgery (67 citations), Genetics (38 citations) and Aging (2 citations). Thomas Rathjen has collaborated with scholars based in Germany, United States and Denmark. Frequent co-authors include Matthew N. Poy, Matthias Selbach, Matthias D. Sury, Hans‐Hermann Wessels, Sudhir Gopal Tattikota, Heike Naumann, Francesca M. Spagnoli, Marc R. Friedländer, Christian Rask‐Madsen and Wei Chen. Their work appears in journals such as Diabetes, Journal of Biological Chemistry, Arteriosclerosis Thrombosis and Vascular Biology, Molecular & Cellular Proteomics and Oncogene.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.